Close Menu

NEW YORK – The Jackson Laboratory announced on Wednesday that it has received $2.5 million from the Mark Foundation for Cancer Research to study the influence of host genetics on response to immunotherapy.

The researchers, who are conducting the study in mice, are aiming to generate new insights on which cancer patients will respond positively to immunotherapies, based on their genetic backgrounds. The project, "Dissecting the Genetic Control of Response to Immune Checkpoint Inhibitors in Cancer," has implications for how oncologists prescribe a treatment regimen, the lab noted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.